TECHFIELDS PHARMA CO., LTD. v. COVANCE, INC.

UNITED STATES DISTRICT COURT □ DISTRICT OF NEW JERSEY TECHFIELDS PHARMA CO., LTD., Plaintiff, Civil Action No. 16-1148 (RK) GBD) □ MEMORANDUM ORDER COVANCE, INC., et al., Defendants.

KIRSCH, District Judge THIS MATTER comes before the Court upon a letter from Defendants Covance, Inc. and Fisher Clinical Services, ‘Tne. (collectively, “Defendants”) requesting supplemental Daubert briefing and oral argument, (ECF No. 346), in connection with Defendants’ motions to exclude the testimony of Plaintiff's damages expert, Mr. Jeffrey B. Baresciano, (ECF Nos. 205, 209), Plaintiff Techfields Pharma Co., Ltd. (“Plaintiff”) wrote to the Court in opposition to Defendants’ request, (ECF No. 347), and Defendants replied, (ECF No. 351). After considering the parties’ submissions, and recognizing district courts’ “inherent authority to manage their dockets and courtrooms with a view toward the efficient and expedient resolution of cases,” Dietz v. Bouldin, 579 U.S. 40, 47 (2016), IT IS on this 17" day of September, 2024, ORDERED that Defendants’ request for supplemental Daubert briefing and oral argument is DEN IED. ao ROBERT} Kars CH = UNITED STATES DISTRICT JUDGE